Similar Search Results

Multiple criteria decision analysis for value based assessment of new medical technologies: a conceptual framework

Kanavos, Panos; Angelis, Aris - London School of Economics (LSE) - 2013

Assessing the value of new medical technologies may require new approaches that take into account a more comprehensive set of parameters than the incremental cost/QALY. It is argued that MCDA can fulfil this role and has the potential to be methodologically superior to the currently used...

Persistent link: https://www.econbiz.de/10010884583

Medicines in parallel trade in the European Union: a gravity specification

Costa-i-Font, Joan; Kanavos, Panos - London School of Economics (LSE) - 2007

While recent research has explored the phenomenon of drug parallel trade in regulated environments such as the European … is price differences across countries, the propagation mechanism lies in (a) the way drug prices are regulated across … drug prices are regulated. The implications that flow from our study are that a more flexible and competitive and less …

Persistent link: https://www.econbiz.de/10010745350

Is medicines parallel trade ‘regulatory arbitrage’?

Costa-i-Font, Joan - London School of Economics (LSE) - 2015

In the European Union, medicines are regulated products subject to both single market (e.g., regional exhaustion of property rights) and country specific health care regulations (e.g., medicines pricing). This gives rise to parallel trade (PT), a phenomenon that takes place when a patented...

Persistent link: https://www.econbiz.de/10011171762

Patents and the global diffusion of new drugs

Cockburn, Iain; Lanjouw, Jean O.; Schankerman, Mark - London School of Economics (LSE) - 2014

This paper studies how patent rights and price regulation affect how fast new drugs are launched in different countries, using newly constructed data on launches of 642 new drugs in 76 countries for the period 1983-2002, and information on the duration and content of patent and price control...

Persistent link: https://www.econbiz.de/10011126137

Advanced purchase commitments for a malaria vaccine: estimating costs and effectiveness

Berndt, Ernst R.; Glennerster, Rachel; Kremer, Michael R.; … - London School of Economics (LSE) - 2005

To overcome the problem of insufficient research and development (R&D) on vaccines for diseases concentrated in low-income countries, sponsors could commit to purchase viable vaccines if and when they are developed. One or more sponsors would commit to a minimum price that would be paid per...

Persistent link: https://www.econbiz.de/10011071268